CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Open Access
- 1 June 1999
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 28 (2) , 459-477
- https://doi.org/10.1016/s0889-8553(05)70065-0
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitisZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Dysplasia and DNA aneuploidy in a pelvic pouchDiseases of the Colon & Rectum, 1991
- Increased risk of large-bowel cancer in Crohn's disease with colonic involvementThe Lancet, 1990
- Intestinal Cancer in Patients with Crohn's Disease: A Population Study in Central IsraelScandinavian Journal of Gastroenterology, 1989
- Clinical and functional results after restorative proctocolectomyBritish Journal of Surgery, 1988
- Inflammatory bowel disease and leukemiaDigestive Diseases and Sciences, 1986
- Malignancy in Crohn's DiseaseScandinavian Journal of Gastroenterology, 1986
- Sulfasalazine Inhibits the Absorption of Folates in Ulcerative ColitisNew England Journal of Medicine, 1981
- Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis.Gut, 1981
- THE CANCER RISK IN ULCERATIVE COLITISThe Lancet, 1964